Non-statin cholesterol drugs on BlueMedicare Premier Rx (S5795-002)
Ezetimibe, the PCSK9 drugs Repatha and Praluent, and Nexletol, checked against this plan's 2026 formulary (its list of covered drugs).
- Plan type
- Stand-alone drug plan (PDP), Arkansas
- Premium
- $181.20/month
- Deductible
- None
6 of 8 Non-statin cholesterol drugs are covered on this plan. 1 of them require prior authorization.
2 aren't on the formulary (Praluent and icosapent ethyl).
- $5.00Tier 2
- from $340.46Tier 3
- $84.44Tier 3
- $84.09Tier 3
- $5.00Tier 2
- 20%Tier 3
Not on the formulary
Praluent, icosapent ethyl
Patient cost for a 30-day supply at a preferred retail pharmacy. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.